Nepafenac loaded silica nanoparticles dispersed in-situ gel systems: Development and characterization.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Journal of Biological Macromolecules

• Publication date

  2018-04-15

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.ijbiomac.2018.01.123PMID 29408555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.

  2017cited by this paper
• Optimization of thermoreversible poloxamer gel system using QbD principle

  2017cited by this paper
• RES-loaded pegylated CS NPs: for efficient ocular delivery.

  2017cited by this paper
• Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.

  2017cited by this paper
• Nanotechnology-based strategies for treatment of ocular disease

  2016cited by this paper
• The Effect of Silica Nanoparticles on Human Corneal Epithelial Cells

  2016cited by this paper
• Synthesis of SiO2 nanostructures using sol-gel method

  2016cited by this paper
• Liposomes in topical ophthalmic drug delivery: an update

  2016cited by this paper
• Nanoparticles for Ocular Drug Delivery

  2016cited by this paper
• Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation

  2016cited by this paper
• Chitosan/pectin polyelectrolyte complex as a pH indicator.

  2015cited by this paper
• Molecular weight dependence of structure and properties of chitosan oligomers

  2015cited by this paper
• Preparation and Evaluation of Novel In Situ Gels Containing Acyclovir for the Treatment of Oral Herpes Simplex Virus Infections

  2014cited by this paper
• Surface grafted chitosan gels. Part II. Gel formation and characterization.

  2014cited by this paper
• Synthesis and optimization of chitosan nanoparticles: Potential applications in nanomedicine and biomedical engineering

  2014cited by this paper
• Osmolality, pH, and compatibility of selected oral liquid medications with an enteral nutrition product.

  2013cited by this paper
• Preparation and Characterization of Silica Nanoparticles by Wet Mechanical Attrition of White and Yellow Sand

  2013cited by this paper
• Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.

  2013cited by this paper
• Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications

  2012cited by this paper
• Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis.

  2012cited by this paper
• Synthesis of thiolated chitosan and preparation nanoparticles with sodium alginate for ocular drug delivery

  2012cited by this paper
• Nanomaterials for ocular drug delivery.

  2012cited by this paper
• Diclofenac/biodegradable polymer micelles for ocular applications.

  2012cited by this paper
• A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye.

  2011cited by this paper
• Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery

  2011cited by this paper
• Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.

  2011cited by this paper
• Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.

  2011cited by this paper
• Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems

  2010cited by this paper
• Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

  2010cited by this paper
• A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery.

  2010cited by this paper
• Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats.

  2010cited by this paper
• In Situ Forming Formulation: Development, Evaluation, and Optimization Using 33 Factorial Design

  2009cited by this paper
• Evaluation of Pharmasolve® corneal permeability enhancement and its irritation on rabbit eyes

  2009cited by this paper
• Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).

  2007cited by this paper
• Chitin and chitosan: Properties and applications

  2006cited by this paper
• Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use.

  2006cited by this paper
• Physico-chemical studies of the gelation of chitosan in a hydroalcoholic medium.

  2004cited by this paper
• Three-dimensional macroporous calcium phosphate bioceramics with nested chitosan sponges for load-bearing bone implants.

  2002cited by this paper
• Solubilization of Chitosan in Strong Acid Medium

  1999cited by this paper
• Surface activity of water soluble amphiphilic chitin derivatives

  1997cited by this paper
• Chitosan gels: 2. Mechanism of gelation

  1980cited by this paper
• Chitosan gel: a novel polysaccharide gel

  1975cited by this paper

• Novel stable micellar formulation for ocular delivery of nepafenac: optimization, characterization and in-vitro evaluation

  2026cites this paper
• Local Drug Delivery Systems for Cancer Therapy

  2025cites this paper
• Colloidal characterization and drug delivery potential of sesame seed-derived exosome like nanoparticles for ocular application of nepafenac

  2025cites this paper
• Advances in nanomedicine-based retinal drug delivery: mechanisms and translational applications

  2025cites this paper
• In situ gelling systems for ocular drug delivery.

  2024cites this paper
• Absorption enhancement strategies in chitosan-based nanosystems and hydrogels intended for ocular delivery: Latest advances for optimization of drug permeation.

  2024cites this paper
• Molecular interaction of nonsteroidal anti‐inflammatory prodrug nepafenac with ionic surfactants

  2024cites this paper
• A Mini-Review On New Developments In Nanocarriers And Polymers For Ophthalmic Drug Delivery Strategies.

  2023cites this paper
• Development, evaluation and recent progress of ocular in situ gelling drug delivery vehicle based on poloxamer 407

  2023cites this paper
• DEVELOPMENT OF NANO IN SITU GELS OF BEVACIZUMAB FOR THE TREATMENT OF OCULAR ANGIOGENESIS: IN VITRO ASSESSMENT OF ANTI-ANGIOGENESIS ACTIVITY AND MOLECULAR DOCKING ANALYSIS

  2023cites this paper
• Age-Related Macular Degeneration - Therapies and their delivery.

  2023cites this paper
• Nano-based eye drop: topical and noninvasive therapy for ocular diseases.

  2023cites this paper
• Nanoparticles Loaded Thermoresponsive In Situ Gel for Ocular Antibiotic Delivery against Bacterial Keratitis

  2022cites this paper
• Recent progress in colloidal nanocarriers loaded in situ gel in ocular therapeutics

  2022cites this paper
• Nanotechnology-based formulations to amplify intraocular bioavailability

  2022cites this paper
• Nepafenac loaded ophthalmic nanocarriers for treatment of uveitis: A review

  2021cites this paper
• Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo models

  2021cites this paper
• Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route.

  2020cites this paper
• In Situ Polymeric Gels for Topical Drug Delivery

  2020cites this paper
• Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes

  2020cites this paper
• Advanced Biopolymeric Systems for Drug Delivery

  2020cites this paper
• Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments

  2020cites this paper
• Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation

  2020cites this paper
• Promising polymeric drug carriers for local delivery; the case of in situ gels.

  2020cites this paper
• Nanoparticles laden In situ gel for sustained drug release after topical ocular administration

  2020cites this paper
• In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation

  2020cites this paper
• In situ gel containing Bimatoprost solid lipid nanoparticles for ocular delivery: In-vitro and ex-vivo evaluation

  2020cites this paper
• Degradation profile of nepafenac in aqueous solution and structural characterization of a novel degradation product.

  2020cites this paper
• Research progress in the application of in situ hydrogel system in tumor treatment

  2020cites this paper
• A Nasal Temperature and pH Dual-Responsive In Situ Gel Delivery System Based on Microemulsion of Huperzine A: Formulation, Evaluation, and In Vivo Pharmacokinetic Study

  2019cites this paper